Klotho Neurosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLTO and other ETFs, options, and stocks.

About KLTO

Klotho Neurosciences, Inc. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. 

CEO
Joseph Sinkule
CEOJoseph Sinkule
Employees
3
Employees3
Headquarters
Omaha, Nebraska
HeadquartersOmaha, Nebraska
Founded
2004
Founded2004
Employees
3
Employees3

KLTO Key Statistics

Market cap
36.72M
Market cap36.72M
Price-Earnings ratio
-3.27
Price-Earnings ratio-3.27
Dividend yield
Dividend yield
Average volume
19.17M
Average volume19.17M
High today
$1.23
High today$1.23
Low today
$1.06
Low today$1.06
Open price
$1.19
Open price$1.19
Volume
4.22M
Volume4.22M
52 Week high
$3.91
52 Week high$3.91
52 Week low
$0.1135
52 Week low$0.1135

People also own

Based on the portfolios of people who own KLTO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.